Literature DB >> 24294243

In vitro activity of disinfectants against Aspergillus spp.

A S Mattei1, I M Madrid, R Santin, L F D Schuch, M C A Meireles.   

Abstract

Fungi of the Aspergillus genus are widespread and contaminate the environment. Thousands of conidia are released from each phialide and dispersed in the air every day. These fungi are considered important mycose-causing agents in hospitals. Due to this, research to determine prevalent fungi from the Aspergillus genus in hospital environments, and an adequate disinfection program in these areas is are needed. This study evaluated the susceptibility of Aspergillus spp. isolated from a veterinary environment against four disinfectants. Successive dilutions of disinfectants (log2) were used according to CLSI M38-A2 microdilution technique adapted to chemical agents against 18 isolates of this genus. After 72 hours of incubation, the Minimum Inhibiting Concentration and Minimum Fungicidal Concentration capable of inhibiting 50% and 90% of the isolates were determined. Chlorexidine-cetrimine, benzalconium chloride and a chlorophenol derivative proved to be effective against all isolates with a lower MIC than that suggested by the manufacturer, except for the A. flavus strain. Sodium hypochlorite was ineffective against three A. fumigatus, three A. flavus and one A. niger isolate. These results demonstrated that all studied disinfectants were effective against environmental isolates, with the exception of sodium hypochlorite, which showed lower effectiveness.

Entities:  

Keywords:  ammonium quaternary; chlorexidine; chlorophenol derivative; filamentous fungi; sodium hypochlorite

Mesh:

Substances:

Year:  2013        PMID: 24294243      PMCID: PMC3833149          DOI: 10.1590/S1517-83822013000200024

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


Introduction

Fungal infections that affect immunocompromised patients are very important due to treatment difficulties, often leading to the patient’s death (Morris ). A study on septicemia epidemiology reported a 207% increase in fungus cases between 1979 and 2000, some of which were related to the Aspergillus genus (Martin ). Invasive aspergillosis, which is primarily caused by Aspergillus fumigatus, followed by A. flavus, A. niger and A. terreus, is one of the causes for the high mortality rate of hospitalized patients. Since this fungus is widespread, countless conidia are released from phialides and dispersed in the air every day, contaminating the environment (Latgé, 1999). Thus, an association of chemoprophylaxis with an environmental support, including positive airway pressure in the rooms, filters for respiratory protection (HEPA) and the elimination of opportunistic fungus sources, is recommended (Falvey and Streifel, 2007). Research to determine the prevalent fungi of the Aspergillus genus in hospital environments has been developed, inasmuch as these are potential infection sources (Morris ; Vonberg and Gastmeier, 2006; Falvey and Streifel, 2007). However, studies in veterinary environments are still scarce (Xavier ; Mattei ). Basic cleaning, disinfection, sterilization and biosafety principles are similar in veterinary hospitals, but, due to some peculiarities, these processes have not been properly standardized and evaluated, resulting in cross contamination and hospital infection risks (Santos ). There are different active principles of disinfectants available, but the spectrum of desired activity, toxicity, residual power, costs and nature of the material still needs to be better defined (McDonell and Russel, 1999). This study evaluated the susceptibility of Aspergillus spp. isolates from veterinary environment surfaces against four disinfectants.

Material and Methods

Isolates and inoculum

Eighteen Aspergillus genus fungal isolates obtained from veterinary hospital surfaces, nine of which were A. fumigatus, seven A. flavus and two A. niger, were tested by the plating technique. To prepare the inoculum, the isolates were previously plated on Petri dishes containing potato dextrose agar (Neogen Acumedia®, Michigan/EUA) and incubated at 35 °C for five days so that pure young cultures could be obtained. After fungal growth, conidia and hyphae were collected from the colony surface and transferred to a sterile test-tube containing 1mL sterile salt and 1% Tween 20. After sedimentation (5 min), the supernatant was transferred to a sterile test-tube and then homogenized in a Vortex test tube shaker for 15 seconds, having its final concentration adjusted to 5 × 104 Colony Forming Units (cfu) mL−1. This suspension was diluted to 1:50 in RPMI-1640, obtaining twice the necessary concentration to be added into each microplate well at the same volume as that of the chemical agent, according to standard protocol. To confirm the fungal inoculum concentration, the Pour-plate technique using Sabouraud dextrose agar Neogen Acumedia, Michigan/EUA and cfu count was performed.

Chemical agents

The in vitro susceptibility test for Aspergillus spp. isolates against disinfectants and antiseptics such as chlorexidine-cetrimide (Chemitec Agro-veterinária, São Paulo, Brazil), sodium hypochlorite (Chemitec Agro-veterinária, São Paulo, Brazil), benzalconium chloride (ammonium quaternary) (Indústria Anhembi S/A, São Paulo, Brazil) and a chlorophenol derivative (Colgate-Palmolive Indústria e Comércio LTDA, São Paulo, Brazil) was performed according to document M38-A2 of the Clinical and Laboratory Standards Institute (CLSI) adapted for chemical agents. Six successive dilutions of the four chemical agents, namely SH (sodium hypochlorite), BC (benzalconium chloride), CC (chlorexidine-cetrimide) and CP (chlorophenol derivative) were prepared in log2 with RPMI-1640 broth (Sigma Chemical Co. Steinheim, Alemanha). The final concentrations of CB, CP and CC disinfectants corresponded respectively to 2; 1; 0.5; 0.25; 0.12 and 0.06 times the recommended concentration used by the manufacturer, and SH corresponded respectively to 4; 2; 1; 0.5; 0.25 and 0.12 times the recommended concentration.

Microdilution test

To perform the broth microdilution technique, twelve sterile microplates (ninety-six wells) were filled with fungal inoculum added with previously diluted disinfectant/antiseptic, and adjusted to RPMI-1640 added with MOPS (Vetec Química Fina LTDA, Rio de Janeiro, Brazil). All samples were tested in duplicate against four disinfectants/antiseptics. The first microplate column (column A) was used as growth control, and was filled with 200 μL inoculum, whereas the last column (column H) was used as sterile control and filled with 200 μL of the highest disinfectant dilution. The other columns (Column B to G) were filled with 100 μL inoculum and 100 μL chemical agent dilution sequentially from the highest to the lowest dilution of the product. The microplates were incubated in a shaker incubator at 35 °C with constant shaking (40 cycles/min), and visual reading of the results was done after 72 hours. The Minimum Inhibitory Concentration (MIC) was established as the highest chemical agent dilution capable of inhibiting fungal growth. The Minimum Fungicidal Concentration (MFC) was estimated by plating 10 μL from all wells and defined as the concentration which did not show apparent fungal growth on Petri dishes added with Sabouraud dextrose agar and chloramphenicol incubated at 35 °C for five days. Finally, the MIC and MFC capable of inhibiting 50% and 90% of the tested isolates were calculated.

Results

The MIC and MFC obtained from four disinfectants and antiseptics against Aspergillus spp. isolates are shown in Table 1. The MFC from six isolates was not performed due to their growth in the most concentrated dilution of the chemical agent.
Table 1

Minimum Inhibitory Concentration and Minimum Fungicidal Concentration of chlorexidine-cetrimide (CC), sodium hypochlorite (SH), chlorophenol derivative (CP) and benzalconium chloride (BC) against Aspergillus spp. isolates.

IsolatesCC (CI:66.7 μL mL−1)SH (CI: 40 μL mL−1)CP (CI: 30 μL mL−1)BC (CI: 20 μL mL−1)




CIMCFMCIMCFMCIMCFMCIMCFM
A.flavus≤ 4.28.3401603.757.5≤ 1.252.5
A. flavus≤ 4.2≤ 4.240407.5152.510
A.flavus≤ 4.2≤ 4.240407.57.52.52.5
A. flavus≤ 4.2≤ 4.240807.51555
A.flavus≤ 4.28.3>160-15302.52.5
A. flavus≤ 4.2≤ 4.280807.57.52.52.5
A.flavus≤ 4.2≤ 4.2>160-30302020
A.fumigatus≤ 4.28.340407.57.52.52.5
A fumigatus≤ 4.28.340807.57.52.52.5
A.fumigatus≤ 4.2≤ 4.240807.57.52.52.5
A.fumigatus≤ 4.2≤ 4.2>160-7.57.52.52.5
A.fumigatus≤ 4.2≤ 4.240403.757.52.55
A.fumigatus≤ 4.2≤ 4.2>160-153055
A.fumigatus≤ 4.28.340803.757.5≤ 1.25≤ 1.25
A.fumigatus≤ 4.2≤ 4.240403.757.52.55
A.fumigatus≤ 4.28.3>160-7.57.52.52.5
A.niger≤ 4.2≤ 4.2>160-15302.52.5
A.niger≤ 4.28.340403.75152.52.5

MIC: Minimum Inhibitory Concentration.

MFC: Minimum Fungicidal Concentration.

CI: Concentration indicated by the disinfectant manufacturer.

Chlorexidine-cetrimide, benzalconium chloride and chlorophenol derivative were effective against all isolates at a lower MIC than that recommended by the manufacturer, except for an A. flavus strain, which was inhibited at the standard concentration for benzalconium chloride and chlorophenol derivative. Sodium hypochlorite was ineffective against three A. fumigatus, three A. flavus and one A. niger isolate at the growth concentration recommended by the manufacturer and the highest concentration tested. The MIC and MFC of disinfectants capable of inhibiting 50% and 90% of the Aspergillus ssp. isolates from veterinary environment surfaces observed in this study are shown in Table 2.
Table 2

Minimum Inhibitory Concentration and Minimum Fungicidal Concentration of the four disinfectants against Aspergillus spp. isolated from an isolates environment.

DisinfectantsMIC (μL mL−1)MFC(μL mL−1)


50%90%50%90%
Benzalconium chloride1.904.22.24.9
Chlorophenol derivative5.311.37.518.2
Sodium hypochlorite55>16072.9>160
Chlorexidine-cetrimide<4.2<4.2<4.27

MIC: Minimum Inhibitory Concentration.

MFC: Minimum Fungicidal Concentration.

Discussion

Hospital environment disinfection is one of the main aspects in nosocomial disease prevention. Thus, the choice of the most adequate product for this purpose is crucial to reduce the occurrence of opportunistic pathogens in these places (Medeiros ; Sherlock ). Pedrini and Margatho (2003) tested different sodium hypochlorite dilutions against standard strains of clinical bacteria causing mastitis and found that the 0.5% dilution was not effective against these isolates. 1% benzalconium chloride was active only against gram positive bacteria, whereas 0.5% chlorexidine obtained the best results against the tested strains. Chlorexidine effectiveness against pathogenic microorganisms such as Staphylococcus spp. and Aspergillus spp. has been described by other authors (Xavier ; Xavier ; Medeiros ). In agreement with these results, this study observed that sodium hypochlorite did not have a satisfactory action against the isolates tested, while chlorexidine-cetrimide showed efficacy against the same Aspergillus spp. isolates. The need for regular assessment of the disinfectants used on dairy farms has been suggested due to the variations in the sensitivity and resistance profile of Staphylococcus genus bacteria to disinfectants, which can jeopardize disease control programs (Medeiros ). In vitro sensitivity studies of fungal pathogens to disinfectants are scarce. Xavier described chlorexidine and the benzalconium chloride efficacy against Aspergillus spp. isolated from a veterinary environment, as well as clinical cases of aspergillosis in penguins. Furthermore, they found that all isolates were iodine-resistant in the tested dilutions. Similarly, Aspergillus spp. isolates were sensitive to disinfectants in this study; however, six species were resistant to sodium hypochlorite and four were sensitive at the standard concentration, showing that this product should not be recommended for disinfection in the research site. According to literature, A. niger is sensitive at a 200μg mL−1 chlorexidine and 100–200 μg mL−1 benzalconium chloride concentration (McDonell and Russel, 1999); however, Xavier (2003) and Xavier demonstrated that a 40 μg mL−1 chlorexidine-cetrimide and a 2.5 μL mL−1 ammonium quaternary derivative concentration sufficed to inhibit the growth of this species. Therefore, our results are in agreement with those in literature in relation to these two disinfectants. At lower concentrations, however, such as 4.2 μg mL−1, chlorexidine-cetrimide and the benzalconium chloride were found to inhibit the growth of this microorganism. The chlorexidine-cetrimide MIC capable of inhibiting 90% of isolates was lower as compared to that of other disinfectants, whereas the SH MIC was higher, though the lowest MFC was obtained from BC. Thus, CC has an action against environment isolates and BC could be used as an alternative disinfectant by reducing costs and avoiding the emergence of resistant strains. In some isolates, MFC differed from MIC for the tested disinfectants, demonstrating the importance of using the correct disinfectant dilution when applying this technique so as to eliminate pathogens in hospital environments more efficiently.

Conclusion

By the the results obtained, it could be concluded that chlorexidine-cetrimide, benzalconium chloride and the chlorophenol derivative were efficient against Aspergillus spp. isolated from veterinary environments, whereas sodium hypochlorite showed lower efficiency.
  7 in total

1.  Is it really clean? An evaluation of the efficacy of four methods for determining hospital cleanliness.

Authors:  O Sherlock; N O'Connell; E Creamer; H Humphreys
Journal:  J Hosp Infect       Date:  2009-03-24       Impact factor: 3.926

Review 2.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

Review 4.  Sampling of Aspergillus spores in air.

Authors:  G Morris; M H Kokki; K Anderson; M D Richardson
Journal:  J Hosp Infect       Date:  2000-02       Impact factor: 3.926

Review 5.  Nosocomial aspergillosis in outbreak settings.

Authors:  R-P Vonberg; P Gastmeier
Journal:  J Hosp Infect       Date:  2006-05-18       Impact factor: 3.926

6.  Ten-year air sample analysis of Aspergillus prevalence in a university hospital.

Authors:  D G Falvey; A J Streifel
Journal:  J Hosp Infect       Date:  2007-08-27       Impact factor: 3.926

Review 7.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

  7 in total
  4 in total

1.  Decontamination of microbiologically contaminated abiotic porous surfaces in an oral surgery clinic using vaporised hydrogen peroxide (VHP).

Authors:  Anna Wawrzyk; Mansur Rahnama; Dorota Rybitwa; Katarzyna Wieczorek; Grzegorz Michalczewski; Edyta Podsiadły; Michał Łobacz
Journal:  J Environ Health Sci Eng       Date:  2020-06-17

2.  Disinfectants in a Hemodialysis Setting: Antifungal Activity Against Aspergillus and Fusarium Planktonic and Biofilm Cells and the Effect of Commercial Peracetic Acid Residual in Mice.

Authors:  Leonardo G Lopes; Larissa A Csonka; Jessica A Souza Castellane; Alef Winter Oliveira; Sílvio de Almeida-Júnior; Ricardo Andrade Furtado; Cibele Tararam; Larissa Ortolan Levy; Leandro Zuccolotto Crivellenti; Maria Luiza Moretti; Maria José S Mendes Giannini; Regina H Pires
Journal:  Front Cell Infect Microbiol       Date:  2021-04-29       Impact factor: 5.293

3.  Water-Transmitted Fungi are Involved in Degradation of Concrete Drinking Water Storage Tanks.

Authors:  Monika Novak Babič; Nina Gunde-Cimerman
Journal:  Microorganisms       Date:  2021-01-12

4.  Post-Flood Impacts on Occurrence and Distribution of Mycotoxin-Producing Aspergilli from the Sections Circumdati, Flavi, and Nigri in Indoor Environment.

Authors:  Daniela Jakšić; Miranda Sertić; Sándor Kocsubé; Ivana Kovačević; Domagoj Kifer; Ana Mornar; Biljana Nigović; Maja Šegvić Klarić
Journal:  J Fungi (Basel)       Date:  2020-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.